| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 23 | 2022 | 3450 | 2.950 |
Why?
|
| Heart Defects, Congenital | 26 | 2022 | 4258 | 2.480 |
Why?
|
| Hypoplastic Left Heart Syndrome | 11 | 2023 | 528 | 2.260 |
Why?
|
| Ventricular Outflow Obstruction | 6 | 2018 | 272 | 1.660 |
Why?
|
| Pulmonary Artery | 12 | 2020 | 1901 | 1.610 |
Why?
|
| Tetralogy of Fallot | 6 | 2022 | 573 | 1.590 |
Why?
|
| Truncus Arteriosus, Persistent | 3 | 2020 | 58 | 1.510 |
Why?
|
| Fiber Optic Technology | 4 | 2021 | 290 | 1.290 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2022 | 480 | 1.180 |
Why?
|
| Heart Valve Diseases | 3 | 2020 | 1057 | 1.080 |
Why?
|
| Fontan Procedure | 6 | 2019 | 739 | 1.050 |
Why?
|
| Aortic Valve | 4 | 2016 | 1822 | 1.040 |
Why?
|
| Norwood Procedures | 6 | 2022 | 160 | 1.030 |
Why?
|
| Heart Conduction System | 2 | 2020 | 1032 | 0.990 |
Why?
|
| Heart Septal Defects | 3 | 2022 | 179 | 0.960 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2020 | 488 | 0.960 |
Why?
|
| Pneumonectomy | 7 | 2005 | 1073 | 0.820 |
Why?
|
| Heart Transplantation | 13 | 2015 | 3081 | 0.790 |
Why?
|
| Pulmonary Valve | 5 | 2020 | 401 | 0.760 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2019 | 29 | 0.750 |
Why?
|
| Atrioventricular Block | 1 | 2020 | 110 | 0.720 |
Why?
|
| Williams Syndrome | 1 | 2020 | 182 | 0.700 |
Why?
|
| Polytetrafluoroethylene | 2 | 2018 | 239 | 0.670 |
Why?
|
| Microscopy, Confocal | 3 | 2020 | 2040 | 0.660 |
Why?
|
| Mitochondria, Muscle | 1 | 2016 | 174 | 0.560 |
Why?
|
| Intraoperative Care | 1 | 2019 | 784 | 0.530 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 810 | 0.520 |
Why?
|
| Lung Transplantation | 12 | 2003 | 1157 | 0.500 |
Why?
|
| Heart Ventricles | 5 | 2021 | 3835 | 0.500 |
Why?
|
| Lung | 14 | 2015 | 9765 | 0.490 |
Why?
|
| Bioprosthesis | 3 | 2016 | 613 | 0.490 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2016 | 497 | 0.480 |
Why?
|
| Tricuspid Valve | 2 | 2022 | 394 | 0.470 |
Why?
|
| Heart Rate | 2 | 2020 | 4102 | 0.430 |
Why?
|
| Pulmonary Circulation | 3 | 2020 | 736 | 0.420 |
Why?
|
| Vena Cava, Inferior | 1 | 2014 | 449 | 0.410 |
Why?
|
| Heart Arrest | 3 | 2019 | 1374 | 0.410 |
Why?
|
| Heart Valve Prosthesis | 3 | 2016 | 1495 | 0.410 |
Why?
|
| Infant | 27 | 2022 | 34497 | 0.380 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2016 | 1487 | 0.380 |
Why?
|
| Child, Preschool | 24 | 2021 | 41181 | 0.370 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2014 | 961 | 0.360 |
Why?
|
| Infant, Newborn | 24 | 2023 | 24645 | 0.350 |
Why?
|
| Reperfusion Injury | 12 | 2003 | 1076 | 0.350 |
Why?
|
| Blood Vessel Prosthesis Implantation | 4 | 2018 | 1315 | 0.330 |
Why?
|
| Myocardium | 3 | 2016 | 4938 | 0.330 |
Why?
|
| Child | 30 | 2022 | 74146 | 0.320 |
Why?
|
| Length of Stay | 4 | 2019 | 6278 | 0.320 |
Why?
|
| Sinoatrial Node | 2 | 2020 | 100 | 0.310 |
Why?
|
| Cyclohexanecarboxylic Acids | 6 | 2002 | 152 | 0.310 |
Why?
|
| Heart | 2 | 2020 | 4326 | 0.300 |
Why?
|
| Atrioventricular Node | 2 | 2020 | 176 | 0.300 |
Why?
|
| Airway Management | 2 | 2020 | 311 | 0.290 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 17 | 0.290 |
Why?
|
| Humans | 87 | 2023 | 715124 | 0.280 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2011 | 1356 | 0.260 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2010 | 312 | 0.260 |
Why?
|
| Purines | 6 | 2002 | 603 | 0.260 |
Why?
|
| Hospitals, Pediatric | 2 | 2018 | 1780 | 0.240 |
Why?
|
| Reoperation | 6 | 2019 | 4174 | 0.240 |
Why?
|
| Embolism, Fat | 1 | 2003 | 56 | 0.240 |
Why?
|
| Retrospective Studies | 32 | 2022 | 72255 | 0.240 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 1834 | 0.230 |
Why?
|
| Echocardiography | 3 | 2021 | 5098 | 0.230 |
Why?
|
| Purinergic P1 Receptor Agonists | 4 | 2002 | 39 | 0.220 |
Why?
|
| Heart Arrest, Induced | 3 | 2019 | 364 | 0.220 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2021 | 1089 | 0.220 |
Why?
|
| Tracheobronchomalacia | 2 | 2020 | 118 | 0.220 |
Why?
|
| Postoperative Complications | 11 | 2019 | 15098 | 0.210 |
Why?
|
| Sheep | 2 | 2021 | 1469 | 0.200 |
Why?
|
| Pulmonary Alveoli | 2 | 2002 | 730 | 0.190 |
Why?
|
| Treatment Outcome | 22 | 2022 | 62186 | 0.190 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3489 | 0.190 |
Why?
|
| Anti-Ulcer Agents | 1 | 2020 | 115 | 0.190 |
Why?
|
| Sheep, Domestic | 1 | 2019 | 46 | 0.180 |
Why?
|
| Mitral Valve | 3 | 2021 | 1458 | 0.180 |
Why?
|
| Peptic Ulcer | 1 | 2020 | 204 | 0.180 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 169 | 0.180 |
Why?
|
| Elastin | 1 | 2020 | 332 | 0.180 |
Why?
|
| Heart Injuries | 2 | 2019 | 202 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2022 | 339 | 0.180 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2002 | 296 | 0.170 |
Why?
|
| Fluorescein | 1 | 2019 | 177 | 0.170 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 383 | 0.170 |
Why?
|
| Tretinoin | 1 | 2001 | 530 | 0.170 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2019 | 210 | 0.170 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 726 | 0.160 |
Why?
|
| Spinal Cord Ischemia | 3 | 2002 | 82 | 0.160 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2016 | 12 | 0.160 |
Why?
|
| Sus scrofa | 2 | 2016 | 455 | 0.160 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 1034 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 256 | 0.160 |
Why?
|
| Time Factors | 15 | 2019 | 41081 | 0.150 |
Why?
|
| Milrinone | 1 | 2016 | 85 | 0.150 |
Why?
|
| Hemangioma | 1 | 2002 | 738 | 0.150 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2016 | 63 | 0.150 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 289 | 0.150 |
Why?
|
| Heart Failure | 4 | 2014 | 10123 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 887 | 0.150 |
Why?
|
| Heart Diseases | 3 | 2022 | 2763 | 0.150 |
Why?
|
| Suture Techniques | 1 | 2001 | 796 | 0.150 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2016 | 221 | 0.150 |
Why?
|
| Male | 51 | 2020 | 351081 | 0.150 |
Why?
|
| Transplantation, Homologous | 2 | 2018 | 4846 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2016 | 1242 | 0.140 |
Why?
|
| Vascular Resistance | 3 | 2016 | 958 | 0.140 |
Why?
|
| Infant Care | 1 | 2017 | 188 | 0.140 |
Why?
|
| Female | 48 | 2020 | 377334 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11402 | 0.140 |
Why?
|
| Organ Size | 6 | 2002 | 2313 | 0.140 |
Why?
|
| Survival Rate | 10 | 2019 | 13255 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2011 | 387 | 0.140 |
Why?
|
| Saphenous Vein | 1 | 2018 | 518 | 0.140 |
Why?
|
| Transplantation, Autologous | 2 | 2018 | 2079 | 0.140 |
Why?
|
| Hospital Mortality | 5 | 2019 | 5133 | 0.130 |
Why?
|
| Lung Diseases | 2 | 2003 | 1897 | 0.130 |
Why?
|
| Aorta, Thoracic | 3 | 2015 | 1038 | 0.130 |
Why?
|
| Cell Division | 5 | 2002 | 4739 | 0.130 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2014 | 276 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2002 | 2033 | 0.130 |
Why?
|
| Palliative Care | 5 | 2018 | 3289 | 0.130 |
Why?
|
| Ventricular Dysfunction | 2 | 2012 | 141 | 0.130 |
Why?
|
| Device Removal | 1 | 2019 | 659 | 0.120 |
Why?
|
| Hypothermia, Induced | 2 | 2017 | 715 | 0.120 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 580 | 0.120 |
Why?
|
| Patient Selection | 3 | 2016 | 4320 | 0.120 |
Why?
|
| Risk Adjustment | 1 | 2017 | 588 | 0.120 |
Why?
|
| Animals | 26 | 2021 | 170726 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 1062 | 0.120 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 1986 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19499 | 0.120 |
Why?
|
| Trachea | 1 | 2019 | 1085 | 0.120 |
Why?
|
| Stroke Volume | 2 | 2019 | 4570 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 444 | 0.110 |
Why?
|
| Regeneration | 2 | 2002 | 1543 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 516 | 0.110 |
Why?
|
| Heart Bypass, Right | 1 | 2012 | 77 | 0.110 |
Why?
|
| Troponin I | 1 | 2016 | 634 | 0.110 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2015 | 648 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2001 | 1172 | 0.110 |
Why?
|
| Resuscitation | 1 | 2016 | 652 | 0.110 |
Why?
|
| Models, Animal | 1 | 2019 | 2219 | 0.110 |
Why?
|
| Age Factors | 3 | 2019 | 18789 | 0.110 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2009 | 183 | 0.110 |
Why?
|
| Organ Preservation | 3 | 2002 | 276 | 0.110 |
Why?
|
| Adolescent | 17 | 2019 | 84999 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 2135 | 0.100 |
Why?
|
| Ventricular Function | 2 | 2012 | 423 | 0.100 |
Why?
|
| Action Potentials | 1 | 2019 | 1792 | 0.100 |
Why?
|
| Spinal Cord | 5 | 2002 | 1821 | 0.100 |
Why?
|
| Reperfusion | 2 | 2002 | 291 | 0.100 |
Why?
|
| Alagille Syndrome | 1 | 2010 | 37 | 0.100 |
Why?
|
| Paralysis | 2 | 2002 | 240 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2020 | 8042 | 0.100 |
Why?
|
| Heart-Assist Devices | 5 | 2010 | 1231 | 0.100 |
Why?
|
| Coronary Angiography | 3 | 2018 | 4401 | 0.100 |
Why?
|
| Oxygen | 3 | 2017 | 4169 | 0.100 |
Why?
|
| Stents | 2 | 2020 | 3303 | 0.100 |
Why?
|
| Prostheses and Implants | 3 | 2009 | 1343 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2014 | 576 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2016 | 1512 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2014 | 5943 | 0.090 |
Why?
|
| Blood Group Incompatibility | 1 | 2009 | 129 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2015 | 1509 | 0.090 |
Why?
|
| Rabbits | 10 | 2003 | 5149 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2010 | 713 | 0.090 |
Why?
|
| Pulmonary Atresia | 1 | 2009 | 150 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2013 | 8602 | 0.080 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2009 | 144 | 0.080 |
Why?
|
| Young Adult | 8 | 2019 | 56155 | 0.080 |
Why?
|
| Heart Function Tests | 2 | 2012 | 334 | 0.080 |
Why?
|
| ABO Blood-Group System | 1 | 2009 | 363 | 0.080 |
Why?
|
| Fibrosis | 1 | 2014 | 1944 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 1890 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2002 | 6123 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 4924 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2018 | 7836 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2020 | 6403 | 0.080 |
Why?
|
| Swine | 3 | 2019 | 5807 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 2751 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2013 | 852 | 0.070 |
Why?
|
| Aneurysm | 1 | 2008 | 325 | 0.070 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2002 | 115 | 0.070 |
Why?
|
| Child Development | 1 | 2017 | 2179 | 0.070 |
Why?
|
| Risk Assessment | 8 | 2019 | 23511 | 0.070 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 39285 | 0.070 |
Why?
|
| Receptor, Adenosine A2A | 5 | 2002 | 133 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2002 | 5441 | 0.070 |
Why?
|
| Wound Healing | 2 | 2009 | 2797 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2018 | 10531 | 0.060 |
Why?
|
| Risk Factors | 10 | 2022 | 70704 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 2008 | 1385 | 0.060 |
Why?
|
| Thiocarbamates | 1 | 2003 | 32 | 0.060 |
Why?
|
| Antibodies | 1 | 2012 | 2445 | 0.060 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 18345 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2018 | 946 | 0.060 |
Why?
|
| Graft Rejection | 4 | 2012 | 4409 | 0.060 |
Why?
|
| Prolapse | 1 | 2022 | 59 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 1225 | 0.060 |
Why?
|
| Rats | 4 | 2013 | 25090 | 0.060 |
Why?
|
| Cryopreservation | 2 | 2010 | 630 | 0.060 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2002 | 64 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 2 | 2010 | 1478 | 0.060 |
Why?
|
| Polyethylene Terephthalates | 1 | 2002 | 108 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15258 | 0.060 |
Why?
|
| Intensive Care Units | 3 | 2020 | 3441 | 0.060 |
Why?
|
| Filtration | 1 | 2003 | 236 | 0.060 |
Why?
|
| Brachiocephalic Trunk | 1 | 2001 | 39 | 0.060 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 3422 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7225 | 0.050 |
Why?
|
| Thrombosis | 1 | 2015 | 2852 | 0.050 |
Why?
|
| Adult | 15 | 2019 | 212129 | 0.050 |
Why?
|
| Pyrrolidines | 1 | 2003 | 345 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2020 | 51181 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2002 | 186 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 12567 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 443 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2012 | 3769 | 0.050 |
Why?
|
| Shock | 1 | 2003 | 319 | 0.050 |
Why?
|
| Angiography | 2 | 2008 | 1668 | 0.050 |
Why?
|
| Epoprostenol | 1 | 2001 | 279 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2001 | 393 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2001 | 218 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2001 | 192 | 0.050 |
Why?
|
| Sternum | 1 | 2001 | 166 | 0.050 |
Why?
|
| Zoonoses | 1 | 2001 | 153 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 1745 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 462 | 0.050 |
Why?
|
| Suction | 1 | 2001 | 262 | 0.050 |
Why?
|
| Gadolinium | 2 | 2001 | 910 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2001 | 959 | 0.050 |
Why?
|
| Recovery of Function | 3 | 2018 | 2950 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 2001 | 423 | 0.040 |
Why?
|
| Capillaries | 1 | 2002 | 778 | 0.040 |
Why?
|
| Multiple Trauma | 1 | 2001 | 368 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 939 | 0.040 |
Why?
|
| Aneurysm, False | 1 | 2001 | 285 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2008 | 2007 | 0.040 |
Why?
|
| Boston | 3 | 2018 | 9400 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2001 | 441 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2020 | 263 | 0.040 |
Why?
|
| Particle Size | 1 | 2003 | 1695 | 0.040 |
Why?
|
| Perfusion | 1 | 2002 | 1267 | 0.040 |
Why?
|
| Angina Pectoris | 1 | 2002 | 1010 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2003 | 668 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2002 | 815 | 0.040 |
Why?
|
| Mucus | 1 | 2019 | 315 | 0.040 |
Why?
|
| Aneurysm, Dissecting | 1 | 2003 | 647 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2001 | 6531 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2009 | 2158 | 0.040 |
Why?
|
| Graft Survival | 4 | 2018 | 3761 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2012 | 4281 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2001 | 965 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 1008 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1701 | 0.040 |
Why?
|
| Adenosine | 1 | 2001 | 831 | 0.040 |
Why?
|
| Perioperative Care | 2 | 2016 | 1070 | 0.040 |
Why?
|
| Cardiomyopathies | 2 | 2012 | 1829 | 0.040 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2008 | 2126 | 0.040 |
Why?
|
| Oxyhemoglobins | 1 | 2016 | 214 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2005 | 2363 | 0.030 |
Why?
|
| Middle Aged | 15 | 2019 | 214871 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 1001 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2001 | 800 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 1467 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2002 | 4353 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1689 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2020 | 1854 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2001 | 983 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2012 | 2678 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6802 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2001 | 847 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2012 | 4226 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1444 | 0.030 |
Why?
|
| Aorta | 1 | 2022 | 2118 | 0.030 |
Why?
|
| Papillary Muscles | 1 | 2013 | 199 | 0.030 |
Why?
|
| Leukocytes | 1 | 2001 | 2102 | 0.030 |
Why?
|
| United States | 4 | 2019 | 67665 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 971 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 2013 | 458 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 2436 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2936 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1939 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2121 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 2144 | 0.030 |
Why?
|
| Computer Systems | 1 | 2013 | 483 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 2398 | 0.030 |
Why?
|
| Quality of Life | 1 | 2012 | 11691 | 0.030 |
Why?
|
| Body Weight | 1 | 2002 | 4692 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 736 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 34394 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2016 | 1125 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 988 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2001 | 1502 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2001 | 2064 | 0.030 |
Why?
|
| Cross Infection | 1 | 2020 | 1410 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2412 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8998 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2017 | 5028 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4476 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 2299 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 1933 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1562 | 0.020 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2009 | 47 | 0.020 |
Why?
|
| Replantation | 1 | 2010 | 149 | 0.020 |
Why?
|
| Birth Weight | 1 | 2017 | 1927 | 0.020 |
Why?
|
| Peroxidase | 2 | 2002 | 624 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 919 | 0.020 |
Why?
|
| North America | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 919 | 0.020 |
Why?
|
| Bronchitis | 1 | 2009 | 209 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2094 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2019 | 2970 | 0.020 |
Why?
|
| Neurologic Examination | 2 | 2001 | 957 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 8010 | 0.020 |
Why?
|
| Critical Illness | 1 | 2020 | 2532 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2012 | 741 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 480 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7159 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12477 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6779 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 228 | 0.020 |
Why?
|
| Cause of Death | 2 | 2012 | 3587 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2009 | 582 | 0.020 |
Why?
|
| Respiratory Function Tests | 2 | 2001 | 1671 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2038 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 11900 | 0.020 |
Why?
|
| Cardiology | 1 | 2017 | 1651 | 0.020 |
Why?
|
| Macrophages | 1 | 2001 | 5805 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1649 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 1453 | 0.020 |
Why?
|
| Apoptosis | 1 | 2001 | 10112 | 0.020 |
Why?
|
| Algorithms | 1 | 2005 | 13669 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 960 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 6994 | 0.020 |
Why?
|
| Parents | 1 | 2017 | 3160 | 0.020 |
Why?
|
| Aged | 8 | 2003 | 162674 | 0.020 |
Why?
|
| Reference Values | 2 | 2001 | 5061 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9561 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 804 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 4916 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 516 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 39804 | 0.020 |
Why?
|
| Thoracic Surgery | 1 | 2009 | 684 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2009 | 985 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3998 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 249 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 344 | 0.010 |
Why?
|
| Micropore Filters | 1 | 2001 | 23 | 0.010 |
Why?
|
| Blood Pressure | 3 | 2002 | 8566 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 1110 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12404 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2017 | 3748 | 0.010 |
Why?
|
| Vacuum | 1 | 2001 | 62 | 0.010 |
Why?
|
| Lung Compliance | 1 | 2001 | 218 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1401 | 0.010 |
Why?
|
| Occlusive Dressings | 1 | 2001 | 54 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 422 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 560 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2001 | 240 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6750 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29168 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 720 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 16011 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2001 | 364 | 0.010 |
Why?
|
| Pneumonia, Bacterial | 1 | 2002 | 316 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2001 | 392 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 2001 | 411 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 1104 | 0.010 |
Why?
|
| Debridement | 1 | 2001 | 499 | 0.010 |
Why?
|
| Aerosols | 1 | 2001 | 690 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2001 | 363 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 2001 | 549 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 1677 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2002 | 762 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2001 | 730 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3879 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 2480 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2001 | 14877 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10423 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2003 | 2579 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 5039 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 3628 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 23283 | 0.010 |
Why?
|
| Intracranial Aneurysm | 1 | 2001 | 1303 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 6131 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3933 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2001 | 1494 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5258 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 13594 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 14326 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2002 | 15260 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13302 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 22936 | 0.000 |
Why?
|
| Neurons | 1 | 2001 | 9419 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20398 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 58505 | 0.000 |
Why?
|
| Mice | 1 | 2002 | 80995 | 0.000 |
Why?
|